When to take probiotics

Are probiotics taken on an empty or full stomach?

The only comparison available comes from a laboratory model. Tompkins and colleagues measured the survival of a single commercial product in capsule form containing four microorganisms (two Lactobacillus, one Bifidobacterium and Saccharomyces cerevisiae boulardii) in a model simulating the upper digestive tract. For all the bacteria, survival was best when the product was given with a meal or 30 minutes before a meal (cooked oatmeal with milk) and low when given 30 minutes after a meal. In 1% fat milk and oat milk porridge, survival was significantly better than in apple juice or spring water. S. boulardii was not affected by meal timing or the buffering capacity of the meal. The authors concluded that fat content, rather than protein, may be important, and that bacterial probiotics without enteric coating should ideally be taken with a meal containing fat or just before a meal. The lead author’s institutional affiliation is a company that manufactures probiotics. ^[1]

The limits of this result are: one product, one laboratory model, no human outcome. That is, higher survival does not show that there is more benefit in diarrhea or another clinical outcome, and it cannot be generalized to other products (for example, enteric-coated or with different strains).

Are probiotics taken together with antibiotics?

In the reviews examining antibiotic-associated diarrhea, the probiotic was given together with the antibiotic. In the Cochrane review covering 33 trials in children, follow-up ranged from 5 days to 12 weeks, and products were compared with placebo, alternative prophylaxis or no-treatment control. ^[2] The 42-trial meta-analysis in adults reports that giving the probiotic together with the antibiotic (“co-administration”) reduced the risk of diarrhea. ^[3]

How many hours to leave between the probiotic dose and the antibiotic dose was not addressed as a separate variable in these cited reviews; whether recommended intervals in practice change the clinical outcome was not measured in these trials. For people considering a probiotic while taking antibiotics, timing is planned together with a physician or pharmacist. The 2025 Cochrane review states that short-term probiotic use is unlikely to be associated with adverse effects in people taking systemic antibiotics who do not have suppressed immunity. ^[5]

Why does the timing question remain unanswered in trials?

The variables compared in the reviews are not timing. The 2025 Cochrane C. difficile review performed its prespecified subgroup analyses by risk of bias, probiotic dose, species, adult versus child, inpatient versus outpatient, and event rate in the control group. ^[5] In the BMJ Open meta-analysis in adults, subgroups were set up by species and dose. ^[3] The prespecified subgroup analysis on which the Cochrane review in children relies is also dose. ^[2] An answer at the clinical outcome level to the questions “with a meal or before a meal, how many hours after the antibiotic” therefore cannot be drawn from these trials.

In what form was the probiotic given in the trials?

In the Cochrane review examining upper respiratory tract infections, probiotics were given mostly with a milk-based food in children, as powder in adults, and with a milk-based food or as capsules in older adults. ^[4] This shows which forms the trials used; it does not show that any form is more effective than another.

How long are probiotics used?

No common duration has been established; trials differ widely in duration of use. In antibiotic-associated diarrhea, follow-up in pediatric trials ranged from 5 days to 12 weeks. ^[2] In most trials on preventing upper respiratory tract infections, one or two strains, 10⁹ or 10¹¹ CFU per day and use longer than three months were involved. ^[4] These are the regimens used in the trials; they are not a recommendation.

No criterion for when to stop was tested in these trials. Although the high-dose subgroup in children (≥5 billion CFU/day) appeared more effective, the review states that this finding needs to be confirmed by a large trial. ^[2]

Does suitability come before timing?

Timing detail comes after the question of whether the product is suitable for that person. The Cochrane review in children states that serious adverse effects were not attributed to probiotics in the trials, but that in observational reports outside the trials, serious events were reported in children with a central venous catheter or with disease involving bacterial or fungal translocation, in severely ill or immunosuppressed children. ^[2] The adverse effect result of the C. difficile review also applies to people with non-suppressed immunity who use probiotics short-term. ^[5] In these groups, probiotic use and timing are decided together with a physician.

Do probiotics survive stomach acid?

In the Tompkins model, bacterial survival varied with meal conditions; the yeast (S. boulardii) was not affected. ^[1] Survival is therefore a product- and strain-specific property. The number of live organisms reaching the gut cannot be derived from the CFU on the label with this data.

How are probiotics stored, and when is the CFU on the label valid?

For supplements, the relationship between storage (refrigerator or room temperature) and maintenance of CFU throughout shelf life was not measured in the studies cited on this page; the product’s label and the manufacturer’s instructions apply. There are two pieces of information from regulatory texts. The Codex fermented milk standard stipulates that starter microorganisms must be viable, active and abundant until the expiry date; this requirement does not apply to products heat treated after fermentation. ^[6] In the health claims list in Türkiye, the condition for the probiotic claim was that the product contain at least 1.0×10⁶ CFU/g of live probiotic microorganisms; the list states that the assessment of this claim is continuing and that it has been “suspended.” ^[7] The announcement of September 27, 2024 by TİTCK (Turkish Medicines and Medical Devices Agency) includes changing the claim condition to at least 1.0×10⁸ CFU/g of at least one microorganism species in daily intake. ^[8] The two figures show that the CFU on the label is related to a legal claim condition; it is not a clinical benefit threshold.

This guide does not recommend person-specific timing or doses; for people taking medication, with suppressed immunity or severely ill, the view of a physician or pharmacist is essential.